Over the past quarter, shares of Ascendis Pharma A/S have risen 57.65%, and are up 30.9% in the last year. On the other hand, the S&P 500 has only moved 11.57% and 22.53%, respectively. Investors should also take note of ASND's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. Right now, ASND is averaging 443,988 shares for the last 20 days. Earnings Outlook The Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with ASND. Over the past two months, 7 earnings estimates moved higher compared to none lower for the full year.